Strong association of hepatitis C virus (HCV) infection and thrombocytopenia: implications from a survey of a community with hyperendemic HCV infection.
about
The pathophysiology of thrombocytopenia in chronic liver diseaseBenign and Malignant Hematological Manifestations of Chronic Hepatitis C Virus InfectionThe role of gender on clearance of hepatitis C virus: a different story in an area endemic for hepatitis B and CIs Hepatitis C Infection Associated With a Higher Risk of Complications After Total Shoulder Arthroplasty?Cutaneous, pulmonary and hepatic sarcoidosis associated with autoimmune complications during interferon-alpha treatment for hepatitis C virus infection.Platelet autoantibodies are common in hepatitis C infection, irrespective of the presence of thrombocytopenia.Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan.Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients.Autoimmune thrombocytopenia related to chronic hepatitis C virus infection.Antiplatelet antibodies contribute to thrombocytopenia associated with chronic hepatitis C virus infection.Trends in the prevalence of thrombocytopenia among individuals infected with hepatitis C virus in the United States, 1999-2008Effect of splenectomy on platelets associated antibodies in hepatitis C patients with thrombocytopenia.Partial Splenic Embolization as a Bridge to Total Knee Replacement for a Patient with Severe Thrombocytopenia due to Cirrhosis and Splenic Sequestration.Incident severe thrombocytopenia in veterans treated with pegylated interferon plus ribavirin for chronic hepatitis C infection.Association between IPTA gene polymorphisms and hematological abnormalities in hepatitis C virus-infected patients receiving combination therapy.Prevalence of thrombocytopenia among Chinese adult antiretroviral-naïve HIV-positive patients.Non-cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapy.Prevalence of Thrombocytopenia and Its Association with Serum Magnesium.Impact of Helicobacter pylori eradication on refractory thrombocytopenia in patients with chronic HCV awaiting antiviral therapy.Thrombocytopenia in Patients with Chronic Hepatitis C Virus InfectionPredictors for Early Identification of Hepatitis C Virus InfectionMetabolic Dysregulation in Hepacivirus Infection of Common Marmosets (Callithrix jacchus).Inhibition of PAR-4 and P2Y12 receptor-mediated platelet activation produces distinct hepatic pathologies in experimental xenobiotic-induced cholestatic liver disease.Selected biochemical and hematological abnormalities in Nigerians with human immunodeficiency virus and hepatitis C virus coinfection.The molecular prevalence of viral infections in transplant candidates with bone marrow suppression, shiraz, southern iran, 2010.Decreased anti-hepatitis C virus titer and associated factors in chronic hepatitis C patients after sustained virological response: a prospective study.Quantitative Platelet Abnormalities in Patients With Hepatitis B Virus-Related Liver Disease.Human blood platelets and viruses: defense mechanism and role in the removal of viral pathogens
P2860
Q26749277-E97F21B2-BB13-46F6-95CB-BF8BA5FCDE94Q26775733-9E42704A-A255-4842-B67D-3A0039FC7A44Q27480976-5BEA2597-24E7-4EC9-93DF-1CC7FB1B1559Q30275569-C85622A4-2F38-4DF4-93A0-1DE1561783A1Q33371011-BFF9459D-1918-4F93-8B89-934A6E930068Q33372989-1225F9DF-0115-4AFF-B9B9-50E934A12254Q33373735-275428B8-C26D-4715-8248-80DFFBCC030BQ33378075-F20F2B6E-1499-4C42-9D44-76E60C805D3AQ33382854-67D6D585-86A5-46E9-92E5-DF026AC055A0Q33386712-E881C06E-DABD-4C6D-8F2A-5DC64690F6DDQ33400231-52367AF2-3146-415E-ACCF-08DC7EE03E74Q33401584-B958B098-86AD-4E83-BD56-4728C9700AE2Q33405215-CC520DCD-2C07-49E8-90CC-584ECD7B86C4Q33414281-7BB477F6-412F-4730-81B4-B5FD82A474E8Q33418008-D16EA1AA-72D5-435F-96FC-BA1D7C9BBF98Q33420327-B9B40B71-F10B-4D45-A9D2-2F534871C353Q33421239-73D7FFE5-8F57-4082-BE62-7BE86D2A132AQ33423721-A8DACF01-015D-4853-A156-0DD42DC8DD10Q33432245-DDEA6BD9-5AC7-4833-9893-04DC56F3CFEFQ33440130-C60FE1E9-6FCE-436C-B10B-261AAC80F7C1Q36043559-FA026407-20C7-46B9-A7DB-D9D7FCF0A212Q36248995-9EAABD97-3AC8-4522-A170-1188E029C61CQ37387670-6153CBB2-4F5B-4CC6-8D47-BCAE32FBD68BQ42140762-6F2BC8D8-0BC3-4127-89C3-4A374B6F0708Q42727267-833CBB33-1892-4E1D-8925-030399E988F5Q43041377-C981D97C-340C-467E-BF11-1DB521A417DDQ47142999-A3120A40-EBF7-431D-AE19-43086AFEB852Q57027381-289B6B21-6214-4037-9BAB-BDD95506C319
P2860
Strong association of hepatitis C virus (HCV) infection and thrombocytopenia: implications from a survey of a community with hyperendemic HCV infection.
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Strong association of hepatiti ...... th hyperendemic HCV infection.
@ast
Strong association of hepatiti ...... th hyperendemic HCV infection.
@en
type
label
Strong association of hepatiti ...... th hyperendemic HCV infection.
@ast
Strong association of hepatiti ...... th hyperendemic HCV infection.
@en
prefLabel
Strong association of hepatiti ...... th hyperendemic HCV infection.
@ast
Strong association of hepatiti ...... th hyperendemic HCV infection.
@en
P2093
P356
P1476
Strong association of hepatiti ...... th hyperendemic HCV infection.
@en
P2093
Chong-Shan Wang
Pesus Chou
Shan-Tair Wang
Ting-Tsung Chang
Wei-Jen Yao
P304
P356
10.1086/423384
P407
P577
2004-08-27T00:00:00Z